These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas. Mebarki S; Désert R; Sulpice L; Sicard M; Desille M; Canal F; Dubois-Pot Schneider H; Bergeat D; Turlin B; Bellaud P; Lavergne E; Le Guével R; Corlu A; Perret C; Coulouarn C; Clément B; Musso O Oncotarget; 2016 Jun; 7(26):39026-39043. PubMed ID: 27191501 [TBL] [Abstract][Full Text] [Related]
3. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma. Tsai HW; Cheng SW; Chen CC; Chen IW; Ho CL BMC Cancer; 2023 Oct; 23(1):1025. PubMed ID: 37875822 [TBL] [Abstract][Full Text] [Related]
4. Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling. Lei ZJ; Wang J; Xiao HL; Guo Y; Wang T; Li Q; Liu L; Luo X; Fan LL; Lin L; Mao CY; Wang SN; Wei YL; Lan CH; Jiang J; Yang XJ; Liu PD; Chen DF; Wang B Oncogene; 2015 Jun; 34(24):3188-98. PubMed ID: 25893304 [TBL] [Abstract][Full Text] [Related]
5. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855 [TBL] [Abstract][Full Text] [Related]
6. Changes in Wnt and TGF-β Signaling Mediate the Development of Regorafenib Resistance in Hepatocellular Carcinoma Cell Line HuH7. Karabicici M; Azbazdar Y; Ozhan G; Senturk S; Firtina Karagonlar Z; Erdal E Front Cell Dev Biol; 2021; 9():639779. PubMed ID: 34458250 [TBL] [Abstract][Full Text] [Related]
7. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients. Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924 [TBL] [Abstract][Full Text] [Related]
8. LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma. Vieira GC; Chockalingam S; Melegh Z; Greenhough A; Malik S; Szemes M; Park JH; Kaidi A; Zhou L; Catchpoole D; Morgan R; Bates DO; Gabb PD; Malik K Oncotarget; 2015 Nov; 6(37):40053-67. PubMed ID: 26517508 [TBL] [Abstract][Full Text] [Related]
9. Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma. Lv Z; Yu JJ; Zhang WJ; Xiong L; Wang F; Li LF; Zhou XL; Gao XY; Ding XF; Han L; Cai YF; Ma W; Wang LX Oncotarget; 2017 Apr; 8(16):26492-26504. PubMed ID: 28404917 [TBL] [Abstract][Full Text] [Related]
10. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion. Tung EK; Wong BY; Yau TO; Ng IO PLoS One; 2012; 7(5):e36565. PubMed ID: 22570728 [TBL] [Abstract][Full Text] [Related]
12. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells. Fafilek B; Krausova M; Vojtechova M; Pospichalova V; Tumova L; Sloncova E; Huranova M; Stancikova J; Hlavata A; Svec J; Sedlacek R; Luksan O; Oliverius M; Voska L; Jirsa M; Paces J; Kolar M; Krivjanska M; Klimesova K; Tlaskalova-Hogenova H; Korinek V Gastroenterology; 2013 Feb; 144(2):381-391. PubMed ID: 23142137 [TBL] [Abstract][Full Text] [Related]
13. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Yamashita T; Budhu A; Forgues M; Wang XW Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5 (LGR5) Represents a Typical Wnt/β-Catenin Pathway-Activated Hepatocellular Carcinoma. Effendi K; Yamazaki K; Fukuma M; Sakamoto M Liver Cancer; 2014 Oct; 3(3-4):451-7. PubMed ID: 26280006 [TBL] [Abstract][Full Text] [Related]
15. Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma. Tsui YM; Sze KM; Tung EK; Ho DW; Lee TK; Ng IO Oncotarget; 2017 Jun; 8(24):39430-39442. PubMed ID: 28455968 [TBL] [Abstract][Full Text] [Related]
16. Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cells. Fukuma M; Tanese K; Effendi K; Yamazaki K; Masugi Y; Suda M; Sakamoto M Exp Cell Res; 2013 Feb; 319(3):113-21. PubMed ID: 23127514 [TBL] [Abstract][Full Text] [Related]
17. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E Cells; 2020 May; 9(5):. PubMed ID: 32408542 [TBL] [Abstract][Full Text] [Related]
18. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma. Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788 [TBL] [Abstract][Full Text] [Related]
19. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway. Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042 [TBL] [Abstract][Full Text] [Related]
20. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells. Ma X; Wang B; Wang X; Luo Y; Fan W PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]